{"id":343349,"date":"2026-11-10T23:39:35","date_gmt":"2026-11-10T18:09:35","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/"},"modified":"2026-11-10T23:39:35","modified_gmt":"2026-11-10T18:09:35","slug":"suraksha-diagnostic-q2-results-fy27-pat-15-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/","title":{"rendered":"SURAKSHA DIAGNOSTIC Q2 Results FY27: Net Profit Jumps 69.31%, Revenue Rs 99.07 Cr, PAT Rs 14.95 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">SURAKSHA DIAGNOSTIC Q2 Results FY27 were declared on 10 November 2026 on a Consolidated basis. The quarterly results show revenue of Rs 99.07 Cr, up 25.84% YoY from Rs 78.73 Cr, while net profit rose 69.31% YoY to Rs 14.95 Cr from Rs 8.83 Cr. Operating Profit reached Rs 34.81 Cr, and YoY growth in all three lines is the core of the quarter.<\/p>\n<\/div>\n<p><a href=\"https:\/\/univest.in\/stocks\/suraksha\/suraksha-diagnostic-limited-share-price-today\">SURAKSHA DIAGNOSTIC LIMITED<\/a> (SURAKSHA) Q2 Results FY27 announced on 10 November 2026, covering the company&#8217;s financial performance for the July to September quarter. The results date brought consolidated results with revenue of Rs 99.07 Cr and PAT of Rs 14.95 Cr, both higher than a year earlier. Investors following SURAKSHA DIAGNOSTIC Q2 Results FY27 can see revenue up 25.84% and PAT up 69.31% on the same quarter last year.<\/p>\n<p>This results analysis of SURAKSHA DIAGNOSTIC Q2 Results covers the financial highlights, business drivers, outlook and risks behind the numbers. It opens with the Financial Highlights table, which sets this quarter beside the same quarter last year.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_Financial_Highlights\" title=\"SURAKSHA DIAGNOSTIC Q2 Results FY27: Financial Highlights\">SURAKSHA DIAGNOSTIC Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Key_Takeaways_from_SURAKSHA_DIAGNOSTIC_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from SURAKSHA DIAGNOSTIC Q2 Results: What Stands Out\">Key Takeaways from SURAKSHA DIAGNOSTIC Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_Performance_Analysis\" title=\"SURAKSHA DIAGNOSTIC Q2 Results FY27: Performance Analysis\">SURAKSHA DIAGNOSTIC Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#FY27_Outlook_After_SURAKSHA_DIAGNOSTIC_Q2_Results\" title=\"FY27 Outlook After SURAKSHA DIAGNOSTIC Q2 Results\">FY27 Outlook After SURAKSHA DIAGNOSTIC Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Key_Risks_to_Watch_After_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"Key Risks to Watch After SURAKSHA DIAGNOSTIC Q2 Results FY27\">Key Risks to Watch After SURAKSHA DIAGNOSTIC Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Per-Share_Profit_Decline\" title=\"Per-Share Profit Decline\">Per-Share Profit Decline<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Volatile_Quarterly_Net_Profit\" title=\"Volatile Quarterly Net Profit\">Volatile Quarterly Net Profit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Lower_Return_on_Equity\" title=\"Lower Return on Equity\">Lower Return on Equity<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Frequently_Asked_Questions_on_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"Frequently Asked Questions on SURAKSHA DIAGNOSTIC Q2 Results FY27\">Frequently Asked Questions on SURAKSHA DIAGNOSTIC Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_are_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What are SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What are SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_is_the_results_date_for_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What is the results date for SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What is the results date for SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_revenue_was_reported_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What revenue was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What revenue was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_net_profit_was_reported_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What net profit was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What net profit was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#How_much_YoY_growth_did_revenue_show_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"How much YoY growth did revenue show in SURAKSHA DIAGNOSTIC Q2 Results FY27?\">How much YoY growth did revenue show in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Did_net_profit_rise_or_fall_in_SURAKSHA_DIAGNOSTIC_Q2_Results\" title=\"Did net profit rise or fall in SURAKSHA DIAGNOSTIC Q2 Results?\">Did net profit rise or fall in SURAKSHA DIAGNOSTIC Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_was_the_Operating_Profit_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What was the Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What was the Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Are_SURAKSHA_DIAGNOSTIC_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are SURAKSHA DIAGNOSTIC Q2 Results consolidated results or standalone results?\">Are SURAKSHA DIAGNOSTIC Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_business_factors_shaped_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What business factors shaped SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What business factors shaped SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_are_the_key_risks_after_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\" title=\"What are the key risks after SURAKSHA DIAGNOSTIC Q2 Results FY27?\">What are the key risks after SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#What_is_the_outlook_after_SURAKSHA_DIAGNOSTIC_Q2_Results\" title=\"What is the outlook after SURAKSHA DIAGNOSTIC Q2 Results?\">What is the outlook after SURAKSHA DIAGNOSTIC Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/suraksha-diagnostic-q2-results-fy27-pat-15-crore\/#Where_can_I_find_the_complete_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_data\" title=\"Where can I find the complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data?\">Where can I find the complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>SURAKSHA DIAGNOSTIC Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q2 FY26 (Sep 25)<\/th>\n<th>YoY Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 99.07 Cr<\/td>\n<td>Rs 78.73 Cr<\/td>\n<td>+25.84% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 34.81 Cr<\/td>\n<td>Rs 24.11 Cr<\/td>\n<td>+44.38% YoY<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 14.95 Cr<\/td>\n<td>Rs 8.83 Cr<\/td>\n<td>+69.31% YoY<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for SURAKSHA DIAGNOSTIC Q2 Results FY27, 10 November 2026. Figures in Rs Crore, Consolidated basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_SURAKSHA_DIAGNOSTIC_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from SURAKSHA DIAGNOSTIC Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> Rs 99.07 Cr in Q2 against Rs 78.73 Cr a year earlier, a rise of 25.84% on a YoY basis.<\/li>\n<li><strong>Net profit:<\/strong> Rs 14.95 Cr versus Rs 8.83 Cr in the comparison quarter, an increase of 69.31% YoY.<\/li>\n<li><strong>Operating Profit:<\/strong> Rs 34.81 Cr against Rs 24.11 Cr last year, a gain of 44.38% YoY in SURAKSHA DIAGNOSTIC Q2 Results FY27.<\/li>\n<li><strong>Net profit margin:<\/strong> 15.1% in the quarter, up from 11.2% in the comparison quarter.<\/li>\n<li><strong>Return on capital employed:<\/strong> 24.97% in FY26, the latest full-year reading alongside the quarter.<\/li>\n<li><strong>Next step:<\/strong> The performance analysis shows how revenue, Operating Profit and net profit moved together, and why YoY growth matters.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>SURAKSHA DIAGNOSTIC Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The numbers show revenue and profit both moving up YoY. Revenue reached Rs 99.07 Cr from Rs 78.73 Cr, Operating Profit climbed to Rs 34.81 Cr from Rs 24.11 Cr, and net profit rose to Rs 14.95 Cr from Rs 8.83 Cr in the July to September 2026 quarter.<\/p>\n<p>Profit grew faster than revenue. Revenue added 25.84% YoY, Operating Profit added 44.38% and net profit added 69.31%, so each profit line expanded at a faster pace than the top line. This SURAKSHA DIAGNOSTIC Q2 Results FY27 results analysis shows that gap clearly, and the net profit margin of 15.1% against 11.2% reflects it.<\/p>\n<p>One quarter does not set a trend, so readers of SURAKSHA DIAGNOSTIC Q2 Results will want to see how later filings compare with these figures. The quarterly results also raise a natural question about the business factors disclosed for the quarter, which is where the discussion moves next.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue Growth<\/strong> &#8211; The business factors behind SURAKSHA DIAGNOSTIC Q2 Results FY27 start with revenue, which grew 25.8% year on year to Rs 99.07 Cr in the latest quarter. Revenue is the top line from which the Operating Profit of Rs 34.81 Cr and net profit of Rs 14.95 Cr follow.<\/p>\n<p><strong>Net Profit Margin<\/strong> &#8211; Net profit margin improved to 15.1% from 11.2% in the comparison quarter. In these quarterly results, net profit rose 69.3% year on year to Rs 14.95 Cr, which is a faster pace than the revenue increase.<\/p>\n<p><strong>Return on Capital Employed<\/strong> &#8211; Return on capital employed was 24.97% in FY26, which gives context to the profit figures above. It is a full-year measure, so it sits alongside the Q2 numbers rather than inside them.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_SURAKSHA_DIAGNOSTIC_Q2_Results\"><\/span><strong>FY27 Outlook After SURAKSHA DIAGNOSTIC Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The results analysis for FY27 rests on the Q2 figures already declared. Revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr are the latest reference points, and full-year FY27 results will depend on the quarters that follow and on disclosed conditions in the business. Reported figures, not forecasts, are the basis here.<\/p>\n<p>For SURAKSHA DIAGNOSTIC Q2 Results FY27, the quarter gives a base of Rs 34.81 Cr in Operating Profit and a 15.1% net profit margin. Readers can follow the next filing on the Univest app and the Univest Screener to see how these figures compare, and the risks below frame what to watch.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After SURAKSHA DIAGNOSTIC Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Per-Share_Profit_Decline\"><\/span><strong>Per-Share Profit Decline<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Annual per-share profit has slipped sharply between FY24 and FY26. That annual record sits alongside the higher Q2 figures, so SURAKSHA DIAGNOSTIC Q2 Results FY27 need to be read together with the longer history.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Volatile_Quarterly_Net_Profit\"><\/span><strong>Volatile Quarterly Net Profit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Quarterly net profit has been volatile, ranging from Rs 6.28 Cr to Rs 14.95 Cr over the last 5 quarters. The latest figure sits at the top of that range, so the YoY growth of 69.31% should be read against it.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lower_Return_on_Equity\"><\/span><strong>Lower Return on Equity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity declined to 13.81% in FY26 from 15.93% in FY25. This is an annual measure, so it moves slowly and remains worth tracking in later results.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>SURAKSHA DIAGNOSTIC Q2 Results FY27 show revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr, both higher YoY. These quarterly results come on a consolidated results basis, and the Univest app can help investors follow the next filing. For SURAKSHA DIAGNOSTIC Q2 Results, readers should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on SURAKSHA DIAGNOSTIC Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What are SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SURAKSHA DIAGNOSTIC Q2 Results FY27 cover the July to September 2026 quarter, declared on 10 November 2026, with revenue of Rs 99.07 Cr. Alongside this, net profit was Rs 14.95 Cr, as the Financial Highlights table shows.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What is the results date for SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The results date for SURAKSHA DIAGNOSTIC Q2 Results FY27 is 10 November 2026, when the company declared its Q2 numbers. This results date also frames the Quick Answer and the opening paragraphs, which carry the same figures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What revenue was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SURAKSHA DIAGNOSTIC reported revenue of Rs 99.07 Cr, compared with Rs 78.73 Cr a year earlier, so growth was 25.84% YoY. This links to the Performance Analysis section, where revenue is read against profit.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What net profit was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit of Rs 14.95 Cr was reported for SURAKSHA DIAGNOSTIC, against Rs 8.83 Cr a year earlier, a rise of 69.31%. The Key Takeaways section places this net profit beside the margin of 15.1%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_YoY_growth_did_revenue_show_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>How much YoY growth did revenue show in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue grew 25.84% YoY, moving from Rs 78.73 Cr to Rs 99.07 Cr in the quarter. This YoY growth is covered in the Performance Analysis section, alongside Operating Profit and net profit.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_SURAKSHA_DIAGNOSTIC_Q2_Results\"><\/span><strong>Did net profit rise or fall in SURAKSHA DIAGNOSTIC Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose in SURAKSHA DIAGNOSTIC Q2 Results, up 69.31% YoY to Rs 14.95 Cr from Rs 8.83 Cr. That rise outpaced revenue, so the Key Business Factors section links it to the margin of 15.1%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27 was Rs 34.81 Cr against Rs 24.11 Cr a year earlier, a rise of 44.38% YoY. Compared with revenue growth of 25.84%, this is covered in the Performance Analysis.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_SURAKSHA_DIAGNOSTIC_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are SURAKSHA DIAGNOSTIC Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Yes, SURAKSHA DIAGNOSTIC Q2 Results are consolidated results, as the company reported on a Consolidated basis. This means the figures follow the consolidated statement, and the Quick Answer states the basis alongside the results date.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What business factors shaped SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue growth of 25.8%, a net profit margin of 15.1% against 11.2%, and return on capital employed of 24.97% in FY26 are the business factors listed for the quarter. The Key Business Factors section explains each one.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27\"><\/span><strong>What are the key risks after SURAKSHA DIAGNOSTIC Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks are a sharp annual decline in per-share profit, volatile quarterly net profit between Rs 6.28 Cr and Rs 14.95 Cr, and return on equity of 13.81% in FY26. The Key Risks section covers each one.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_SURAKSHA_DIAGNOSTIC_Q2_Results\"><\/span><strong>What is the outlook after SURAKSHA DIAGNOSTIC Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SURAKSHA DIAGNOSTIC Q2 Results give a base for FY27, with revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr. Full-year FY27 results will depend on later quarters, as the Outlook section explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_SURAKSHA_DIAGNOSTIC_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data can be followed on the Univest app and the Univest Screener, while this article covers the main figures. The Financial Highlights table lists revenue, Operating Profit and net profit side by side.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SURAKSHA DIAGNOSTIC Q2 Results FY27 cover the July to September 2026 quarter, declared on 10 November 2026, with revenue of Rs 99.07 Cr. Alongside this, net profit was Rs 14.95 Cr, as the Financial Highlights table shows.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The results date for SURAKSHA DIAGNOSTIC Q2 Results FY27 is 10 November 2026, when the company declared its Q2 numbers. This results date also frames the Quick Answer and the opening paragraphs, which carry the same figures.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SURAKSHA DIAGNOSTIC reported revenue of Rs 99.07 Cr, compared with Rs 78.73 Cr a year earlier, so growth was 25.84% YoY. This links to the Performance Analysis section, where revenue is read against profit.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit of Rs 14.95 Cr was reported for SURAKSHA DIAGNOSTIC, against Rs 8.83 Cr a year earlier, a rise of 69.31%. The Key Takeaways section places this net profit beside the margin of 15.1%.\"}},{\"@type\":\"Question\",\"name\":\"How much YoY growth did revenue show in SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue grew 25.84% YoY, moving from Rs 78.73 Cr to Rs 99.07 Cr in the quarter. This YoY growth is covered in the Performance Analysis section, alongside Operating Profit and net profit.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in SURAKSHA DIAGNOSTIC Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose in SURAKSHA DIAGNOSTIC Q2 Results, up 69.31% YoY to Rs 14.95 Cr from Rs 8.83 Cr. That rise outpaced revenue, so the Key Business Factors section links it to the margin of 15.1%.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit in SURAKSHA DIAGNOSTIC Q2 Results FY27 was Rs 34.81 Cr against Rs 24.11 Cr a year earlier, a rise of 44.38% YoY. Compared with revenue growth of 25.84%, this is covered in the Performance Analysis.\"}},{\"@type\":\"Question\",\"name\":\"Are SURAKSHA DIAGNOSTIC Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Yes, SURAKSHA DIAGNOSTIC Q2 Results are consolidated results, as the company reported on a Consolidated basis. This means the figures follow the consolidated statement, and the Quick Answer states the basis alongside the results date.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue growth of 25.8%, a net profit margin of 15.1% against 11.2%, and return on capital employed of 24.97% in FY26 are the business factors listed for the quarter. The Key Business Factors section explains each one.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after SURAKSHA DIAGNOSTIC Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key risks are a sharp annual decline in per-share profit, volatile quarterly net profit between Rs 6.28 Cr and Rs 14.95 Cr, and return on equity of 13.81% in FY26. The Key Risks section covers each one.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after SURAKSHA DIAGNOSTIC Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"SURAKSHA DIAGNOSTIC Q2 Results give a base for FY27, with revenue of Rs 99.07 Cr and net profit of Rs 14.95 Cr. Full-year FY27 results will depend on later quarters, as the Outlook section explains.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete SURAKSHA DIAGNOSTIC Q2 Results FY27 data can be followed on the Univest app and the Univest Screener, while this article covers the main figures. The Financial Highlights table lists revenue, Operating Profit and net profit side by side.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"SURAKSHA DIAGNOSTIC Q2 Results FY27: Net Profit Jumps 69.31%, Revenue Rs 99.07 Cr, PAT Rs 14.95 Cr\",\"description\":\"SURAKSHA DIAGNOSTIC Q2 Results: Consolidated revenue \u20b999.07 Cr, PAT \u20b914.95 Cr. Check YoY growth and quarterly results analysis, 10 November 2026.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"SURAKSHA DIAGNOSTIC LIMITED\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>SURAKSHA DIAGNOSTIC Q2 Results FY27: revenue Rs 99.07 Cr up 25.84% YoY, net profit Rs 14.95 Cr up 69.31% YoY, declared 10 November 2026.<\/p>\n","protected":false},"author":29,"featured_media":343348,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-343349","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["343348"],"rank_math_title":["SURAKSHA DIAGNOSTIC Q2 Results FY27: PAT Up 69.31% to Rs 14.95 Cr"],"rank_math_description":["SURAKSHA DIAGNOSTIC Q2 Results: Consolidated revenue \u20b999.07 Cr, PAT \u20b914.95 Cr. Check YoY growth and quarterly results analysis, 10 November 2026."],"rank_math_focus_keyword":["SURAKSHA DIAGNOSTIC Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/suraksha-diagnostic-q2-results-fy27-net-profit-jumps-69-31-revenue-rs-99-07-cr.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343349","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=343349"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/343349\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/343348"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=343349"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=343349"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=343349"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}